Judge Mulls Revival Of Nexium Pay-For-Delay Row

Law360, New York (March 7, 2014, 6:37 PM EST) -- A Massachusetts federal judge on Friday requested further briefing on whether he should reconsider portions of an order that granted victories to drugmakers Ranbaxy Inc. and Teva Pharmaceutical Industries Ltd. in a pay-for-delay class action involving the heartburn drug Nexium.

U.S. District Judge William G. Young denied a flurry of motions for reconsideration stemming from his multi-pronged Feb. 12 order, but laid out an expedited briefing schedule with regard to a pair of direct purchaser class plaintiffs' motions to give the Teva and Ranbaxy summary judgment...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.